Isfahan University of Medical Sciences

Science Communicator Platform

Share By
Benefit of Psyllium With Weight Loss Diet in Preventing Liver Dysfunction in Overweight or Obese Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (Masld) Publisher

Summary: Could psyllium help people with fatty liver disease? In a 10-week trial, psyllium plus lifestyle advice improved BMI, waist size and liver markers versus control. #LiverHealth #Nutrition

Akbarzadeh Z ; Nourian M ; Askari G ; Maracy M R ; Amani R
Authors

Source: International Journal of Preventive Medicine Published:2026


Abstract

Abstract – Introduction: – MASLD is the revised nomenclature of nonalcoholic fatty liver disease (NAFLD) which is the most common chronic liver disease worldwide and it significantly impacts the burden of the disease. Individuals who are overweight or obese have three times higher risk of developing MASLD. Losing body weight is, therefore, recommended to manage MASLD. This study was performed to assess the effect of psyllium on liver function in overweight or obese adults with (MASLD). Methods: – We assessed 80 overweight or obese MASLD patients diagnosed by elastography. They were divided into intervention and placebo groups through randomized block design. Intervention group was given 10 grams of psyllium and the control group was given 10 grams of ground wheat as supplement. Weight loss diet and physical activity (PA) recommendations were followed by both groups for 10 weeks. Serum liver enzymes, liver function (measured by fibroscan), PA, and dietary intake were assessed pre- and post-intervention. Results: – Totally, 78 participants finished the RCT. After controlling confounding variables, intake of calorie (P = 0.02), carbohydrate (P = 0.01), alanine aminotransferase (P = 0.006), waist circumference (P = 0.006), BMI (P = 0.006), and liver fibrosis score (0.001) were lowered in the intervention group compared with the controls. However, serum aspartate aminotransferase reduction was not significant (P = 0.98). Conclusions: – Psyllium can be introduced as a dietary supplement that exerts beneficial role in gut health, weight loss, and preventing MASLD. © 2026 International Journal of Preventive Medicine
Related Docs
View other Related Docs
1. The Effect of Psyllium on Anthropometric Measurements and Liver Enzymes in Overweight or Obese Adults With Nonalcoholic Fatty Liver Disease (Nafld), Journal of Isfahan Medical School (2015)
2. Sesame Oil Ameliorates Alanine Aminotransferase, Aspartate Aminotransferase, and Fatty Liver Grade in Women With Nonalcoholic Fatty Liver Disease Undergoing Low-Calorie Diet: A Randomized Double-Blind Controlled Trial, International journal of clinical practice (2022)
3. Effect of Paleolithic-Based Low-Carbohydrate Vs. Moderate-Carbohydrate Diets With Portion-Control and Calorie-Counting on Ctrp6, Asprosin and Metabolic Markers in Adults With Metabolic Syndrome: A Randomized Clinical Trial, Clinical Nutrition ESPEN (2022)
Experts (# of related papers)
View all Related Experts
Gholamreza Askari (4)
Mohammad Hassan Entezari (2)
Benefit of Psyllium With Weight Loss Diet in Preventing Liver Dysfunction in Overweight or Obese Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (Masld)
Other Related Docs
4. Efficacy of Orlistat for the Treatment of Metabolic Dysfunction–Associated Steatotic Liver Disease Patients: A Systematic Review and Meta-Analysis, Hepatology Forum (2025)
5. The Effect of a Moderately Restricted Carbohydrate Diet on Cardiometabolic Risk Factors in Overweight and Obese Women With Metabolic Syndrome: A Randomized Controlled Trial, Clinical Therapeutics (2023)
6. Effect of Lifestyle Modification Education Based on Health Belief Model in Overweight/Obese Patients With Non-Alcoholic Fatty Liver Disease: A Parallel Randomized Controlled Clinical Trial, Clinical Nutrition ESPEN (2020)
7. The Effect of a Lifestyle Modification Education on Adiposity Measures in Overweight and Obese Nonalcoholic Fatty Liver Disease Patients, International Journal of Preventive Medicine (2017)
8. Efficacy of Empagliflozin on Liver Enzymes, Lipid Profile and Bmi in Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease (Masld): A Systematic Review and Meta-Analysis, Endocrinology, Diabetes and Metabolism (2026)
9. Comparative Study on the Effect of Plantago Psyllium and Ocimum Basilicum Seeds on Anthropometric Measures in Nonalcoholic Fatty Liver Patients, International Journal of Preventive Medicine (2016)
10. Moderate Replacement of Carbohydrates by Dietary Fats Affects Features of Metabolic Syndrome: A Randomized Crossover Clinical Trial, Nutrition (2014)
11. The Effects of Sumac (Rhus Coriaria L.) Powder Supplementation in Patients With Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial, Complementary Therapies in Clinical Practice (2020)
12. Effects of Comprehensive Dietary Advice on the Physical and Mental Health of Patients With Ulcerative Colitis During the Remission Phase: A Parallel Randomized Controlled Clinical Trial, International Journal of Food Properties (2020)
13. Modified Alternate-Day Fasting Vs. Calorie Restriction in the Treatment of Patients With Metabolic Syndrome: A Randomized Clinical Trial, Complementary Therapies in Medicine (2019)
14. Effect of Low-Energy-Dense Diet Rich in Multiple Functional Foods on Weight-Loss Maintenance, Inflammation, and Cardiovascular Risk Factors: A Randomized Controlled Trial, Journal of the American College of Nutrition (2018)
15. Randomized Study of the Effects of Empagliflozin and Topiramate Dual Therapy on Anthropometric and Metabolic Indices in Non-Diabetic Individuals With Overweight/Obesity on a Calorie-Restricted Diet, Eating and Weight Disorders (2024)
16. Adherence to the Dietary Index for Gut Microbiota and the 5-Year Incidence of Metabolic Dysfunction-Associated Steatotic Liver Disease in Iranian Adults: A Prospective Cohort Study, BMC Gastroenterology (2026)
17. Sesame Oil Improves Biomarkers of Glycemic Control in Women With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomized, Double-Blind, Controlled Clinical Trial, BMC Nutrition (2025)
18. Effects of a Moderately-Restricted Carbohydrate Diet on Cardiovascular Risk Factors Among Women With Metabolic Syndrome, Journal of Isfahan Medical School (2012)
19. Effects of a Novel Therapeutic Diet on Liver Enzymes and Coagulating Factors in Patients With Non-Alcoholic Fatty Liver Disease: A Parallel Randomized Trial, Nutrition (2014)
20. Effects of Dietary Whole Grain, Fruit, and Vegetables on Weight and Inflammatory Biomarkers in Overweight and Obese Women, Eating and Weight Disorders (2020)